All Viruses articles – Page 13
-
NewsNewly discovered virus linked to colorectal cancer
Researchers have discovered a previously undescribed virus in a common gut bacterium, Bacteroides fragilis. The virus appears more frequently in patients with colorectal cancer.
-
NewsNew review points to faster, safer vaccine development
A new review examines viral mimic systems that reproduce key features of dangerous pathogens such as SARS-CoV-2, the virus that causes Covid-19, without the ability to replicate or cause disease. These systems allow researchers to study infection safely, quickly, and in a wider range of laboratories.
-
NewsA ring to transcribe them: The unique path of poxviruses
A study shows for the first time the mechanical elegance with which the viral protein VITF-3 controls the transcription process. Vaccinia viruses, the most widely studied model viruses from the poxvirus family, were examined at the molecular level.
-
NewsExposing a hidden anchor for HIV replication
Scientists investigating HIV have revealed a previously unknown role for the viral protein integrase, which helps HIV insert itself into human DNA. A new study provides the first direct evidence that integrase plays a critical structural role earlier on in HIV’s life cycle — when the virus matures into an infectious force.
-
NewsCOVID-19 vaccination during pregnancy may help prevent preeclampsia
A new multinational study has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication.
-
NewsDebilitating virus can spread in cool weather, increasing health risk in Europe
Chikungunya virus, a debilitating tropical disease caused by infected mosquito bites, poses a greater health threat in Europe than previously thought because it can be spread when air temperatures are as low as 13 degrees Celsius.
-
NewsScientists develop first-of-its-kind antibody to block Epstein Barr virus
Using mice with human antibody genes, scientists have developed new genetically human monoclonal antibodies that prevent two key antigens on the surface of the Epstein Barr virus (EBV) from binding to and entering human immune cells.
-
NewsChildren with sleep apnea face higher risk of flu and COVID-19, new study finds
A five-year study has revealed that children with sleep apnea are twice as likely to contract the flu or COVID-19, regardless of their age or weight. Even after undergoing surgery to remove tonsils or adenoids, this increased vulnerability persists due to long-term changes in the immune system.
-
NewsNew antibody–drug conjugate strategy to block HIV infection
New antibody–drug conjugates (ADCs) combine a CD4 mimic with neutralizing antibodies for enhanced suppression of HIV infection. By targeting the gp120 on the viral envelope via a two-step mechanism, the ADCs effectively block viral entry.
-
CareersSummer Studentship: novel antivirals and host-virus interactions
Jessica Harris reports back on her Summer Studentship at De Montfort University, and her research into how plant-derived compounds affect viruses, and whether combining these antivirals might increase viral inhibition.
-
NewsNew biosensor offers early warning system for disease
Researchers have developed a tissue-adhesive sensor for real-time oral health monitoring to combat long-term issues such as gum disease and tooth loss.
-
NewsMpox: recombinant virus with genomic elements of clades Ib and IIb
Recombination of monkeypox virus (MPXV) strains has been documented in recent months, with two cases of a recombinant strain comprising clade Ib and IIb MPXV reported, the World Health Organization says.
-
NewsValneva provides update on recommendations for use of IXCHIQ® in UK
Valneva SE has announced that following a review of the benefits and risks of the Company’s single-dose chikungunya vaccine, IXCHIQ® , the United Kingdom’s (UK) Commission on Human Medicines (CHM) has updated its recommendations for use of the vaccine.
-
NewsImmunity against common virus leveraged against pancreatic cancer
Researchers have discovered a promising new treatment approach for pancreatic cancer. The approach leverages the body’s natural immune response to cytomegalovirus (CMV), a common but typically harmless virus that most people are infected with at some point in their lives.
-
NewsSilent enemies, smart weapons - switching off phage contamination using nanoparticles
Bacteriophages represent a serious threat to laboratories and industries that rely on bacterial cultures for production. Researchers have demonstrated an innovative solution that enables targeting the surface of bacteriophage through electrostatic interactions.
-
NewsFire-footed rope squirrels identified as a natural reservoir for monkeypox virus
A cross-species transmission event documented in Côte d’Ivoire provides new insights into the spread of mpox in the wild.
-
NewsOne strategy to block both drug-resistant bacteria and influenza: new broad-spectrum infection prevention approach validated
A new paper moves beyond traditional infection control strategies reliant on antibiotics and vaccines by introducing a new approach that primes the immune system before infection occurs.
-
NewsProposals for exploring viruses and skin as the next experimental quantum frontiers share US$30,000 science award
Viruses exist at the boundary between living and non-living matter, while skin is a living interface between physics and biology, making them perfect—but until now overlooked—arenas for testing the interplay between quantum physics, biology and life.
-
NewsHIV antibody opens up new approaches for vaccine development and combination therapies
An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. The study opens up new perspectives for the development of vaccines and therapeutics against HIV-1.
-
NewsHPV cancer vaccine slows tumor growth, extends survival in preclinical model
Scientists discovered that systematically changing the orientation and placement of a single cancer-targeting peptide can lead to formulations that supercharge the immune system’s ability to attack HPV-driven tumors.